Services
Expertises
Resources
Who we are
Closed

mCannabis

Funding for cannabis-based pain research

Source change captured

Funding available
$ 300,000
Deadline
Unspecified
Location
Alberta, Canada
Who can apply
Alberta-based post-secondary institutions.
See full eligibility

Overview

This program supports research on cannabis-based medicines and tools to address pain and knowledge gaps in medical cannabis use. Eligible projects may receive up to $300,000 for a maximum term of 24 months.

At a glance

Funding available

Maximum funding
$300,000
Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Conduct research or evaluation activities

Eligible candidates

Location
  • Alberta
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
All groups
Legal structures
All legal structures

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2024
Periods: 1

Latest changes

mCannabis marked inactive

The mCannabis page now shows the program as inactive, and the closed-intake section with the June 1, 2023 registration-closed note has been removed.

See more

The mCannabis page now shows Program Status: Inactive instead of Active. The closed-intake section and its June 1, 2023 registration-closed note were removed from the page.

Eligibility

Who is eligible?

  • Alberta-based post-secondary institutions.
  • Government entities or health delivery agents.
  • Eligible not-for-profit organizations with a presence in Alberta.

Who is not eligible

  • Organizations that are not Alberta-based or do not have a legal and physical presence in Alberta, where required.
  • Applicants that do not meet the program's organization-type requirements.

Eligible expenses

  • Salaries and benefits for staff, students, or contractors working directly on the project.
  • Equipment, materials, supplies, and necessary software licenses.
  • Specialized equipment or services directly related to the project.
  • Travel and accommodation for field work or project dissemination, within program limits.
  • Other costs pre-approved in writing, including project-specific patent filing costs.

Ineligible Costs and Activities

  • Costs incurred before the Investment Agreement is signed.
  • Costs above market price.
  • General administration and indirect overhead costs.
  • Costs for human clinical trials.
  • Expenses outside the project scope or term, or not directly tied to deliverables and milestones.

Eligible geographic areas

  • Alberta

Activities funded

  • Pre-clinical research on cannabis phytochemicals for pain or analgesic properties.
  • Mechanistic studies using model systems or organisms other than humans.
  • Analytical and computational research, including AI or machine learning approaches.
  • Post-market data-focused ideas to improve patient outcomes and support the cannabis industry.

How to apply

  • Submit your application form and supporting information.
  • Wait for your application to be reviewed.
  • If successful, execute an Investment Agreement with Alberta Innovates.

Documents Needed

  • Application form
  • Supporting information
  • Non-confidential graphical abstract

Selection criteria

  • Innovation opportunity, including problem specificity and novelty.
  • Impact potential, including economic, health, and sustainability benefits.
  • Project design and implementation plan, including timeline, milestones, risks, and mitigation.
  • Scientific and technical merit of the proposed research.

Processing and Agreement

  • Applications are reviewed by internal staff and external expert reviewers.
  • Projects are assessed for scientific and technical merit, innovation opportunity, impact potential, and project design.
  • Alberta Innovates makes the funding decision at its sole discretion.
  • Successful applicants must sign an Investment Agreement before funding starts.
  • Progress and performance reporting are part of ongoing project management.

Additional information

  • Alberta Innovates may modify the program guide from time to time.
  • Only the authorized contact named in the application will receive written correspondence.
  • The program includes a Request for Information stream intended to inform a future call.
  • Applications and agreements are subject to Alberta Innovates' sole discretion.

Contacts

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the mCannabis Program

What is the mCannabis?

This program supports research on cannabis-based medicines and tools to address pain and knowledge gaps in medical cannabis use. Eligible projects may receive up to $300,000 for a maximum term of 24 months.

How much funding can be received?

mCannabis Funds up to $300,000 of admissible expenses.

Who is eligible for the mCannabis program?

To be eligible for the mCannabis program, you must: Alberta-based eligible organization. Project meets program milestones and term. Required cannabis licensing or exemptions, if needed.

What expenses are eligible under mCannabis?

Salaries and benefits for staff, students, or contractors working directly on the project. Equipment, materials, supplies, and necessary software licenses. Specialized equipment or services directly related to the project. Travel and accommodation for field work or project dissemination, within program limits. Other costs pre-approved in writing, including project-specific patent filing costs.

Who can I contact for more information about the mCannabis?

You can contact Alberta Innovates by email at Sunil.Rajput@albertainnovates.ca or by phone at 780-603-3905.

Where is the mCannabis available?

The mCannabis program is available the province of Alberta.

Who are the financial supporters of the mCannabis?

mCannabis is funded by Alberta Innovates